NCT03997838View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

May 23, 2019

Primary Completion Date

August 3, 2019

Study Completion Date

August 21, 2019

Conditions
Pain, Postoperative
Interventions
DRUG

VVZ-149 Injections

IV infusion of 1000 mg of VVZ-149

DRUG

Placebo

IV infusion of 0 mg of VVZ-149

Trial Locations (5)

45417

Midwest Clinical Research Center, Dayton

78229

Endeavor Clinical Trials, San Antonio

84107

JBR Clinical Research, Salt Lake City

85053

Arizona Research Center, Phoenix

92801

Anaheim Clinical Trials, Anaheim

All Listed Sponsors
lead

Vivozon, Inc.

INDUSTRY

NCT03997838 - Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty | Biotech Hunter | Biotech Hunter